#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Von Hippel-Lindau disease B-cell lymphoma refractory Follicular lymphoma Systemic mastocytosis Short stature Liposarcoma metastatic Encephalopathy neonatal Mantle cell lymphoma recurrent Chronic lymphocytic leukaemia Infection in an immunocompromised host Chronic myeloid leukaemia (in remission) Congenital ectodermal dysplasia Chondrosarcoma Lip and/or oral cavity cancer Breast angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Diagnostics Leiomyosarcoma metastatic – Basic Information Factor VIII deficiency – Treatment Aicardi-Goutieres syndrome – Trials in Disease Ewing’s sarcoma metastatic – Life with Disease Factor VIII deficiency – Diagnostics Leiomyosarcoma recurrent – Diagnostics Epidermolysis bullosa – Basic Information Choroid melanoma – Basic Information Behcet’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mps-215 Fondaparinux Sodium VIPOGLANSTAT Soya Oil, Purified GRNA1599 Prax-628 Metformin Embonate Glucose, Anhydrous Atorvastatin Calcium Wt1 Mrna Dc Azd5462 SELTOREXANT Hyoscine Butylbromide Phentermine Magnesium Hydroxide INSULIN DETEMIR Dfv890 Ibrexafungerp Ivonescimab ANHYDROUS CALCIUM FOLINATE More therapies…

    Learn about Your Condition

    Arteriovenous graft thrombosis Abdominal pain Neuralgia Retinoblastoma Lower limb fracture Juvenile idiopathic arthritis Kawasaki's disease Ureteric cancer Pericarditis Cutaneous sarcoidosis Hyperparathyroidism primary Wolfram syndrome Varices oesophageal Athetosis Malignant melanoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Myasthenia gravis

  • Study on Zilucoplan Sodium for Children Aged 2 to 17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Zilucoplan Sodium
    • ZILUCOPLAN
    Italy Poland

  • Study on the Long-Term Safety of Zilucoplan in Children with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Zilucoplan Sodium
    • ZILUCOPLAN
    Italy Poland

  • Study on Nipocalimab for Children Aged 2-17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Nipocalimab
    The Netherlands Poland

  • AUR200 for Patients with Generalized Myasthenia Gravis

    Recruiting

    1 1 1
    Investigated Drugs:
    • AUR200
    • Sodium Chloride
    Poland

  • A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

    Recruiting

    4 1 1
    Investigated Drugs:
    • Kyv-101
    Germany

  • A Phase 2a Study of Empasiprubart IV Monotherapy in Adults with AChR‑Ab Seropositive Generalized Myasthenia Gravis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    • Empasiprubart
    Belgium Germany Greece Italy The Netherlands Poland +1
Previous Page
1 2 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!